AzTrials
AzTrials

Unicompartmental Knee ArthroplastyUKANCT02949336

Kinematics Analysis of SIGMA® Partial Knee System

An observational study of Unicompartmental Knee Arthroplasty, run by Stephen Ferguson at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed study is a prospective collection of health related personal data (observational study). A total of approximately 10 subjects with traditional medial SIGMA® High Performance Partial Knee System and 10 ACL deficient subjects with medial SIGMA® High Performance Partial Knee System are analyzed during… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Unicompartmental Knee Arthroplasty
What is being tested?
Observational use of fluoroscopy
Type of treatment
Surgery or procedure
How many people
18 participants
Where
1 siteSwitzerland
Study dates
19 Dec 2016to 11 Dec 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The clinical investigators of the participating clinics (PD Dr. med. Fabian von Knoch, Gelenkzentrum Zürich; and Dr. med. Stefan Preiss, Schulthess Klinik) will identify potential subjects based on clinical records. PD Dr. med. Fabian von Knoch will recruit patients he operated on at the Gelenkzentrum Zürich while Dr. med. Stefan Preiss will recruit subjects from his patient population at the Schulthess Klinik.

Who may be able to join

  • medial SIGMA® High Performance Partial Knee System due to medial OA
  • Intact/functional ACL
  • BMI ≤ 32
  • good clinical outcome, KOOS >70
  • no or very low pain VAS < 2
  • Follow-up at least one year post-op
Show all 18Show fewer
  • Standardized general health survey score (SF-12) within the normal range for people in their age group
  • Age ≥ 18 years
  • medial SIGMA® High Performance Partial Knee System due to medial OA
  • Deficient / non-functional ACL
  • Central to posterior wear of medial tibial plateau (pre-op MRI)
  • 50% reduced tibial posterior slope after UKA (post-op radiograph)
  • BMI ≤ 32
  • good clinical outcome, KOOS >70
  • no or very low pain VAS < 2
  • Follow-up at least one year post-op
  • Standardized general health survey score (SF-12) within the normal range for people in their age group
  • Age ≥ 18 years

Who cannot join

  • Actual significant problem on lower extremities
  • Misaligned UKA
  • Deficient / non-functional ACL (Lachman Test)
  • Any other arthroplasty at the lower extremities
  • Patient incapable to understand and sign informed consent
  • Incapable of performing the motion tasks
Show all 14Show fewer
  • Pregnancy
  • Actual significant problem on lower extremities
  • Misaligned UKA / non-reduced posterior tibial slope (post-op radiograph)
  • Intact / functional ACL
  • Any other arthroplasty at the lower extremities
  • Patient incapable to understand and sign informed consent
  • Incapable of performing the motion tasks
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Institute for Biomechanics, ETH Zurich

    Zurich, Canton of Zurich, 8093

Other trials in Switzerland

About this study

Official title: Kinematics Analysis: Traditional (ACL Retaining) and ACL Deficient (Reduced Tibial Slope) Medial, Fixed Bearing Primary Unicondylar Knee Arthroplasty With the SIGMA® High Performance Partial Knee System

The proposed study is a prospective collection of health related personal data (observational study). A total of approximately 10 subjects with traditional medial SIGMA® High Performance Partial Knee System and 10 ACL deficient subjects with medial SIGMA® High Performance Partial Knee System are analyzed during sitting onto a chair and getting up, deep knee bend, stance and swing phase of level walking, downhill walking (ramp descent) and stair descent at least 12 months post-operatively, in terms of 3D fluoroscopic assessed tibio-femoral motion as well as simultaneous skin marker assessed whole leg motion and ground reaction forces. All the video-fluoroscopic testing is performed at the Institute for Biomechanics at the ETH Zurich. The UKA subjects are recruited based on the inclusion and exclusion criteria.

The primary objective is to quantify and describe the three-dimensional kinematics for patients with a traditional medial SIGMA® High Performance Partial Knee System (functional ACL and tibial posterior slope matching the native bone) during these daily activities.

The secondary objective is to evaluate patients with the same medial UKA implant (SIGMA® High Performance Partial Knee System) in an ACL deficient knee, where the UKA was implanted at a 50% reduced tibial posterior slope relative to the native knee.

Read the detailed description

The knee arthroplasty for each patient was implanted more than one year ago as per inclusion criteria of this study with the sole purpose of standard clinical practice of the recruiting surgeons.

Being tested
Observational use of fluoroscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Observational use of fluoroscopyRadiation

    Minimal radiation exposure (0.17 mSv) for observational purpose

Study groups in NCT02949336
Study groupRoleWhat they receive
Group 1: Traditional UKAPatients with a traditional Medial Unicompartmental Knee Arthroplasty, SIGMA® High Performance Partial Knee System (functional ACL and tibial posterior slope matching the native bone) will undergo observational use of fluoroscopy to analyze joint kinematics
Receives: Radiation: Observational use of fluoroscopy
Group 2: ACL deficient UKAPatients with the same medial UKA implant (SIGMA® High Performance Partial Knee System) in an ACL deficient knee, where the UKA was implanted at a 50% reduced tibial posterior slope relative to the native knee will undergo observational use of fluoroscopy to analyze joint kinematics.
Receives: Radiation: Observational use of fluoroscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Knee Kinematics

    The primary outcome of this study is the relationship between the knee flexion angle and the medial and lateral anterior-posterior translation of the condyles during sitting onto a chair and getting up, deep knee bend, stance and swing phase of level walking, downhill walking (ramp descent) and stair descent.

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2016 (estimated)
  2. Study start19 Dec 2016
  3. Primary completion11 Sep 2017
  4. Study completion11 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02949336
Sponsor's protocol ID
UKA V 2.4 02.09.2016
Acronym
UKA
Status last verified
Jan 2019
First submitted
24 Oct 2016
Last updated
23 Jan 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Unicompartmental Knee Arthroplasty, run by Stephen Ferguson at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 18 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Knee Kinematics (time frame: 3 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in